Nautilus Biotechnology Inc (NASDAQ: NAUT) is a biotechnology company developing a platform for single-molecule protein analysis. The filing excerpts provided do not contain sufficient detail to describe the revenue model, competitive position, geographic footprint, customer base, or financial metrics with the specificity required for a grounded summary. No revenue figures, product commercialization status, customer counts, or competitor names are supported by the excerpts available from the 10-K filed 2026-02-26 (accession 000180880526000011). A complete description cannot be constructed without fabricating facts not present in the source material.

Source: SEC 10-K, filed 2026-02-26

Industry: Laboratory Analytical Instruments Peers: Absci Corp Akoya Biosciences, Inc. Bruker Cellular Analysis, Inc. Codexis Inc Quantum-Si Inc Science 37 Holdings, Inc. Quanterix Corp Rapid Micro Biosystems, Inc Singular Genomics Systems, Inc. Thermo Fisher Scientific Inc